BOEHRINGER INGELHEIM USA CORPORATION, FORMERLY REPORTED AS BOEHRINGER INGELHEIM PHARMACEUTICALS, INC for BOEHRINGER INGELHEIM USA CORPORATION
What was lobbied
6 issue areas, each in the filer's own words, with who lobbied on it and where.
Labor Issues/Antitrust/Workplace LBR
Employee Free Choice Act - monitoring status of bill HR 1409 and S 560
| Lobbyist | Covered position, as disclosed |
|---|---|
| AMY CHEVALIER EFANTIS | LD, Rep. Artur Davis |
| CANDIE PHIPPS | — |
| PAUL ROMNESS | — |
Copyright/Patent/Trademark CPT
Patent reform, Patent settlements; H.R. 1706 and S. 5369
| Lobbyist | Covered position, as disclosed |
|---|---|
| AMY CHEVALIER EFANTIS | LD, Rep. Artur Davis |
| CANDIE PHIPPS | — |
| PAUL ROMNESS | — |
Tariff (miscellaneous tariff bills) TAR
Miscellaneous Tariff Bill; relating to the duty suspension of cyclopropylaminonicotine acid
| Lobbyist | Covered position, as disclosed |
|---|---|
| AMY CHEVALIER EFANTIS | LD, Rep. Artur Davis |
| CANDIE PHIPPS | — |
| PAUL ROMNESS | — |
Health Issues HCR
Health care reform: America's Affordable Health Choices Act, HR 3200 (Education and Labor, Ways and Means, House Energy and Commerce committee drafts), Affordable Health Choices Act, and America's Healthy Future Act (S 1679: Senate HELP and S 1796: Senate Finance committee drafts); pricing/rebates, importation, coverage, comparative effectiveness, biosimilars, transparency
| Lobbyist | Covered position, as disclosed |
|---|---|
| AMY CHEVALIER EFANTIS | LD, Rep. Artur Davis |
| CANDIE PHIPPS | — |
| PAUL ROMNESS | — |
Medicare/Medicaid MMM
Medicare Part D preservation in health reform Rebates, Medicare, Medicaid and Medicaid expansion in health reform
| Lobbyist | Covered position, as disclosed |
|---|---|
| AMY CHEVALIER EFANTIS | LD, Rep. Artur Davis |
| CANDIE PHIPPS | — |
| PAUL ROMNESS | — |
Clean Air and Water (quality) CAW
Pharmaceuticals in the environment - drug take back programs; HR 1191
| Lobbyist | Covered position, as disclosed |
|---|---|
| AMY CHEVALIER EFANTIS | LD, Rep. Artur Davis |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.